MARKET INTEL |
PRIME GRANT

Project - 60NANB22D201

OVERVIEW

Original Description
PURPOSE: THIS APPLICATION REQUESTS CANCER RESEARCH EQUIPMENT FOR THE FOLLOWING AREAS: MICROSCOPIC IMAGING; LEAD DEVELOPMENT OPTIMIZATION; TRANSGENIC AND GENE TARGETING; CRYO-ELECTRON MICROSOPY & DNA REPAIR; CANCER PATHOLOGY SCANNING; CLINICAL PHARMACOLOGY; METABOLIC NUTRITION; AND ESSENTIAL BASIC SCIENCE.ACTIVITIES TO BE PERFORMED: KUCC WILL PROCURE $5.0 MILLION IN NEW EQUIPMENT TO REFRESH THE SHARED USE LABORATORIES SUPPORTING THE CANCER CENTER'S THREE RESEARCH PROGRAMS: CANCER BIOLOGY; CANCER PREVENTION AND CONTROL; AND DRUG DISCOVERY, DELIVERY, AND EXPERIMENTAL THERAPEUTICS.EXPECTED OUTCOMES: THESE NEW INSTRUMENTS WILL HELP PROVIDE THE OPTIMAL ENVIRONMENT TO FOCUS THE POWER OF PRECISION MEDICINE, BASIC SCIENCE INQUIRY, DRUG DISCOVERY AND DEVELOPMENT, AND BEHAVIORAL INTERVENTIONS TO DECREASE CANCER INCIDENCE, MORBIDITY, AND MORTALITY. INTENDED BENEFICIARIES: RESIDENTS OF THE STATE OF KANSAS (105 COUNTIES) AS WELL AS THE 18 NEIGHBORING COUNTIES OF WESTERN MISSOURI WILL BENEFIT FROM THE ENHANCED RESEARCH MADE POSSIBLE BY THE INVESTMENT IN THIS EQUIPMENT. THESE RESIDENTS ARE SERVED BY KUCC, AS IT IS THE ONLY ACADEMIC CANCER CENTER IN THIS REGION.SUBRECIPIENT ACTIVITIES: NO SUBAWARDS WITH THIS APPLICATION.
Assistance Type
Project Grant (B)
Place of Performance
Kansas City, Kansas 66160-8500 USA
Related Opportunity
None

STATUS

Period of Performance

10/1/22

Start Date

9/30/23

End Date
0% Complete

Funding Split

$5.0M

Federal Obligation

$0.0

Non-Federal Obligation

$5.0M

Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

ACTIVITY TIMELINE

SUBGRANT AWARDS

TRANSACTION HISTORY

ADDITIONAL DETAIL

Award ID FAIN
60NANB22D201
SAI Number
60NANB22D201_0
Award ID URI
EXE
Awardee Classifications
Other
Awarding Office
1333ND DEPT OF COMMERCE NIST
Funding Office
1333ND DEPT OF COMMERCE NIST
Last Modified: 9/20/22